发明名称 RECOMBINANT NEWSTLE DISEASE VIRUS AS EMBRYO VACCINE
摘要 PROBLEM TO BE SOLVED: To obtain a Newcastle disease virus(NDV) mutant which is phenotypicaly V protein positive, in which a prescribed amount or less of its P-gene derived from mRNAs in infected cells encode V ORF, and which is useful for a live vaccine to protect birds against NDV and so on. SOLUTION: A Newcastle disease virus(NDV) mutant expresses its V protein at a reduced level (NDV V). The mutant is phenotypically V protein positive, and <=6%, preferably <=3%, more preferably 1%, of its P-gene derived from mRNAs in infected cell encode V ORF. The phosphoprotein (P) gene mRNA editing locus UUU UUC CC (genome RNA sense) comprises a mutation to reduce editing. The mutation in the editin locus is a nucleotide substitution. A live vaccine against Newcastle disease in birds comprises the NDV mutant and a pharmaceutically acceptable carrier.
申请公布号 JP2001069970(A) 申请公布日期 2001.03.21
申请号 JP20000223388 申请日期 2000.07.25
申请人 AKZO NOBEL NV 发明人 MEBATSION TESHOME;SCHRIER CARLA CHRISTINA
分类号 C12N15/09;A61K39/17;A61P31/14;C12N7/00;C12N7/01;C12N7/04;C12N15/45;C12R1/93 主分类号 C12N15/09
代理机构 代理人
主权项
地址